A Prospective Multicentre Real-world Assessment of the Efficacy of Danning Tablets in Alleviating Digestive Symptoms

The goal of this observational study is to evaluate if Danning Tablets are effective in alleviating dyspepsia in patients with any of the following digestive symptoms: upper abdominal pain, bloating, loss of appetite, acid reflux or constipation. The main questions it aims to answer are: How effective are Danning Tablets for patients with indigestion symptoms? What are the impact factors (e.g. severity of conditions, demographic features, dose and length of treatment etc.) of the efficacy of Danning Tablets for indigestion patients? Participants already taking Danning Tablets as part of their regular medical care for indigestion will take questionnaires by the end of two weeks and four weeks respectively from the start of their treatment.

NCT Number	NCT06755671
Lead Sponsor	Shanghai Hutchison Pharmaceuticals Limited Collaborators: Second Affiliated Hospital, Zhejiang University, School of Medicine
Conditions	Indigestion, Dyspepsia, Bloating, Loss of Appetite, Reflux Acid, Constipation, Upper Abdominal Pain, Functional Dyspepsia
Enrollment	4,500 participants
Start Date	2025-04-30
Primary Completion	2027-06-30 (estimated)
Study Completion	2027-06-30 (estimated)
Updated on ClinicalTrials.gov	2025-05-14